Consistent with the result exhibited in Figure 1A, EPHB6 expression was found to have a significantly negative correlation with immunomodulatory genes expression in mesonephric adenocarcinoma (MESO), thyroid carcinoma (THCA), thymoma (THYM), and BLCA. Here, EPHB6 is linked to bladder transitional cell carcinoma.